Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bipolar Disorder I or II”

35 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 35 results

Post-approval studies (Phase 4)Study completedNCT00154323
What this trial is testing

The Efficacy and Safety of Oral Oxcarbazepine 300-1200 mg/Day as Adjuvant Therapy in the Treatment of Bipolar Disorder I or II This Study is Not Being Conducted in the United States.

Who this might be right for
Bipolar Disorder
Novartis 55
Not applicableUnknownNCT04775498
What this trial is testing

Psychoeducation Programmes - Patients With Bipolar Disorder

Who this might be right for
Bipolar Disorder Type I or II (According to DSM-5)
University Hospital, Clermont-Ferrand 352
Large-scale testing (Phase 3)Study completedNCT00194116
What this trial is testing

Double-blind, Placebo-Controlled Divalproex Sodium ER in Bipolar I or Bipolar II Depression

Who this might be right for
Bipolar Disorder
University Hospitals Cleveland Medical Center 54
Large-scale testing (Phase 3)Study completedNCT03249376
What this trial is testing

Lumateperone Monotherapy for the Treatment of Bipolar Depression Conducted Globally

Who this might be right for
Bipolar Depression
Intra-Cellular Therapies, Inc. 381
Post-approval studies (Phase 4)Study completedNCT01430455
What this trial is testing

Tranylcypromine Treatment of Bipolar Depression

Who this might be right for
Bipolar Disorder I or II
New York State Psychiatric Institute 7
Large-scale testing (Phase 3)Looking for participantsNCT06372964
What this trial is testing

Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients

Who this might be right for
Bipolar Depression
Intra-Cellular Therapies, Inc. 384
Testing effectiveness (Phase 2)Ended earlyNCT00771134
What this trial is testing

Efficacy and Safety of Lu AA39959 in Patients With Bipolar Depression

Who this might be right for
Bipolar Disorder
H. Lundbeck A/S 105
Large-scale testing (Phase 3)Ended earlyNCT01131559
What this trial is testing

Adjunctive Lisdexamfetamine (LDX) in Bipolar Depression

Who this might be right for
BipolarDepression
Lindner Center of HOPE 50
Testing effectiveness (Phase 2)Looking for participantsNCT06656416
What this trial is testing

ALTO-100 in Bipolar Disorder With Depression (BD-D)

Who this might be right for
Bipolar Disorder I or II With a Major Depressive Episode
Alto Neuroscience 200
Not applicableNot Yet RecruitingNCT06882590
What this trial is testing

A Compassionate-focused Intervention for Older People with Bipolar Disorder

Who this might be right for
Bipolar Disorder I or II
University of Manchester 6
Large-scale testing (Phase 3)Looking for participantsNCT03423680
What this trial is testing

Abilify® Tablet(Aripiprazole) as an Adjunctive Treatment in the Bipolar Depression

Who this might be right for
Depression, Bipolar
Korea Otsuka Pharmaceutical Co., Ltd. 390
Post-approval studies (Phase 4)Looking for participantsNCT06740890
What this trial is testing

Exercise and Olanzapine-samidorphan

Who this might be right for
Schizophenia DisorderSchizoaffective DisorderBipolar Disorder I or II+1 more
New York State Psychiatric Institute 30
Not applicableLooking for participantsNCT05427123
What this trial is testing

Children's Bipolar Network Treatment Trial I

Who this might be right for
Bipolar DisorderBipolar I DisorderBipolar II Disorder+4 more
University of California, Los Angeles 80
Large-scale testing (Phase 3)Enrolling By InvitationNCT07217860
What this trial is testing

An Open-label Study of Azetukalner in Bipolar I or II Depression (X-CEED-OLE)

Who this might be right for
Bipolar DepressionBipolar I DisorderBipolar Disorder+1 more
Xenon Pharmaceuticals Inc. 400
Large-scale testing (Phase 3)Study completedNCT02600494
What this trial is testing

Clinical Trial Evaluating ITI-007 (Lumateperone) as a Monotherapy for the Treatment of Bipolar Depression

Who this might be right for
Bipolar Depression
Intra-Cellular Therapies, Inc. 554
Testing effectiveness (Phase 2)WithdrawnNCT00204503
What this trial is testing

Open-Label Depakote ER in Patients With Bipolar I or II Depression and Alcohol Abuse or Dependence

Who this might be right for
Bipolar I or II Depression and Alcohol Abuse or Dependence
The University of Texas Medical Branch, Galveston
Large-scale testing (Phase 3)Study completedNCT00254774
What this trial is testing

Efficacy and Safety of Quetiapine Compared With Valproate in the Treatment of Patients With Bipolar Disorder and Rapid Cycling

Who this might be right for
Bipolar Disorder
AstraZeneca 44
Large-scale testing (Phase 3)Study completedNCT00259272
What this trial is testing

Validation of Multidimensional Assessment of THYmic States (MATHYS): A Study in a Population of Bipolar Patients Treated With Olanzapine

Who this might be right for
Bipolar Disorder I or II
Eli Lilly and Company 141
Testing effectiveness (Phase 2)Study completedNCT06605599
What this trial is testing

Study of Oral ABBV-932 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Bipolar I or II Disorder

Who this might be right for
Bipolar I DisorderBipolar II Disorder
AbbVie 161
Testing effectiveness (Phase 2)Study completedNCT01731119
What this trial is testing

Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder+10 more
University of North Carolina, Chapel Hill 9
Load More Results